CTOs on the Move

HemCare Health

www.hemcarehealth.com

 
HemCare Health Services (“HHS”) is a Health Information Exchange company. HHS operates a single unified platform enabling the ability to request and retrieve medical information and records while meeting all of today`s Security & Compliance demands for HIPAA, PIPEDA and PHIPA. Through RecordsBank.org, the Company offers an easy to use online portal to our centralized System for Patients, Lawyers & Insurers to Retrieve and Access Medical Records 24 hours a day, 7 days a week. The centralized system and portal for Patients, Lawyers & Insurers to Retrieve and Access Medical Records is a cloud-based ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Biometrica Systems Inc

Biometrica Systems Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Las Vegas, NV. To find more information about Biometrica Systems Inc, please visit www.biometrica.com

Somanetics Corporation

Somanetics Corporation is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sierra Health Services

Sierra Health Services is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gateway Family House

Gateway Family House is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.